CJC-1295 + Ipamorelin research supply
Review CJC-1295 + Ipamorelin in 10 mg, 20 mg, with 10 vials per box. Select the catalog code and pack specification for your wholesale inquiry. Our team confirms current availability, batch documentation and destination requirements.

Build your inquiry
Availability, packaging and pricing are confirmed by our team.CJC-1295 + Ipamorelin specifications and packaging
| Catalog code | Product / composition | Pack specification |
|---|---|---|
| CP10 | CJC-1295 + Ipamorelin | 10 mg × 10 vials |
| CP20 | CJC-1295 + Ipamorelin | 20 mg × 10 vials |
Each listed pack contains 10 vials. Select the catalog code and specification above, then add your box quantity to the inquiry.
CJC-1295 + Ipamorelin documentation
Contact our team to request the available COA and confirm documentation for your specification and proposed supply batch.
Request COA →Prepare your wholesale request
- Product, specification and number of boxes
- Company, destination country and requested schedule
- Batch-document and packaging requirements
Use the supplier review checklist or review the bulk-order process.
Related catalog products
COMPONENT IDENTITY
CJC-1295 + Ipamorelin: two components
This catalog entry names a combination of two peptides. A blend does not have one covalently connected molecular structure or one molecular formula representing both ingredients as a single compound. Each component needs its own identity reference.
Confirm the CJC-1295 form
CJC-1295 terminology requires care: published analytical work distinguishes CJC-1295 and CJC-1295 with drug affinity complex. The CJC component should be specified by its sequence and modifications before a structure diagram is assigned.
Confirm component quantities
The CP10 and CP20 catalog options list 10 mg and 20 mg pack specifications. Those labels alone do not establish the amount of each component or their ratio. The quotation and batch specification should state CJC-1295 content and Ipamorelin content separately, together with the form of each peptide.
Review analytical coverage
When requesting documentation, ask which component identities and quantities the method addresses. A single overall purity figure should not be read as a separate assay result for each peptide.
Identity reference: Memdouh et al., 2021 · PMID 34665524 ↗. Component structures are not assigned here until the supplied forms are confirmed.
